To directly address the impact of LXRα phosphorylation on NAFLD progression, we have now generated a mouse model harboring an S196A mutation that disrupts LXRα phosphorylation at Ser196. Here, NR1H3 is linked to metabolic dysfunction-associated steatotic liver disease.